LARK Distilling Co. Ltd. (LRKKF)
USD 0.77
(0.0%)
USD 0.77
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -3.63 Million | -5.32 Million | -4.78 Million | -2.42 Million | -3.18 Million |
| Net Income | - | -3.26 Million | -324.58 Thousand | 2.58 Million | -875.97 Thousand | -3.03 Million |
| Depreciation & Amortization | - | 584.23 Thousand | 321.73 Thousand | 154.5 Thousand | 87.48 Thousand | 40.3 Thousand |
| Deferred income taxes | - | 121.43 Thousand | 328.53 Thousand | -1.79 Million | -496.07 Thousand | - |
| Stock-based compensation | - | 793.14 Thousand | 1.01 Million | 556.79 Thousand | 496.07 Thousand | - |
| Change in working capital | - | -1.59 Million | -6.35 Million | -6.14 Million | -2.19 Million | -1.36 Million |
| Other non-cash items | - | 2.37 Million | 8.18 Million | 6.39 Million | 554.56 Thousand | 1.17 Million |
| Investing Cash Flow | -237.03 Thousand | 1.16 Million | -27.25 Million | -478.3 Thousand | -1.08 Million | -497.17 Thousand |
| Investments in PPE | -574.03 Thousand | -542.14 Thousand | -1.55 Million | -590.91 Thousand | -1.08 Million | -497.17 Thousand |
| Acquisitions | - | -739.76 Thousand | -25.7 Million | 112.61 Thousand | 4131.01 | - |
| Investment purchases | - | - | - | - | - | -8801.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 300 Thousand | 2.44 Million | -1.00 | 136.9 Thousand | -0.01 | 8801.00 |
| Financing Cash Flow | -348.79 Thousand | -3.48 Million | 38.4 Million | 6.41 Million | 3.08 Million | 3.59 Million |
| Debt repayment | - | -3.33 Million | -56.5 Thousand | -222.9 Thousand | -3.1 Million | -4.3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1.9 Million | -406.09 Thousand | - | -687.66 Thousand |
| Common Stock Issuance | - | 24.97 Thousand | 38.64 Million | 6.69 Million | - | 7.9 Million |
| Other Financing Activities | -348.79 Thousand | -181.64 Thousand | 3.7 Million | 771.21 Thousand | 6.19 Million | 687.65 Thousand |
| Accounts receivables | - | 1.4 Million | -1.01 Million | -647.15 Thousand | -593.82 Thousand | 186.57 Thousand |
| Accounts payables | - | -1.2 Million | 987.33 Thousand | -108.28 Thousand | 1.26 Million | 316.3 Thousand |
| Inventory | - | -883.4 Thousand | -6.81 Million | -4.91 Million | -3.1 Million | -2.21 Million |
| Other working capital | - | -909.69 Thousand | 493.8 Thousand | -476.69 Thousand | 239.07 Thousand | 351.99 Thousand |
| Cash at beginning of period | 7.15 Million | 11.1 Million | 5.74 Million | 4.21 Million | 4.72 Million | 5.06 Million |
| Cash at end of period | 2.35 Million | 4.76 Million | 11.1 Million | 5.74 Million | 4.21 Million | 4.72 Million |
| Capital Expenditure | -574.03 Thousand | -542.14 Thousand | -1.55 Million | -590.91 Thousand | -1.08 Million | -497.17 Thousand |
| Effect of forex changes on cash | - | -386.63 Thousand | -464.34 Thousand | 380.92 Thousand | -89.17 Thousand | -254.55 Thousand |
| Net cash flow / Change in cash | -4.8 Million | -6.33 Million | 5.36 Million | 1.52 Million | -510.5 Thousand | -345.44 Thousand |
| Free Cash Flow | -574.03 Thousand | -4.17 Million | -6.87 Million | -5.37 Million | -3.51 Million | -3.68 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -1.96 Million | -1.09 Million | -3.26 Million | -2.29 Million | -992.51 Thousand |
| Depreciation & Amortization | - | 345.7 Thousand | 370.22 Thousand | 584.23 Thousand | 326.2 Thousand | 263.99 Thousand |
| Deferred income taxes | - | - | - | 121.43 Thousand | - | - |
| Stock-based compensation | - | - | - | 793.14 Thousand | - | - |
| Change in working capital | - | - | - | -1.59 Million | - | - |
| Other non-cash items | - | 239.34 Thousand | 716.52 Thousand | 2.37 Million | -111.05 Thousand | 340.98 Thousand |
| Investing Cash Flow | -237.03 Thousand | 111.94 Thousand | -275.69 Thousand | 1.16 Million | 1.56 Million | -409.19 Thousand |
| Investments in PPE | -574.03 Thousand | -112.69 Thousand | -275.69 Thousand | -542.14 Thousand | -215.95 Thousand | -333.72 Thousand |
| Acquisitions | - | 24.66 Thousand | - | -739.76 Thousand | -666 Thousand | -75.47 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 300 Thousand | 199.98 Thousand | - | 2.44 Million | 2.44 Million | - |
| Financing Cash Flow | -348.79 Thousand | -149 Thousand | -85.27 Thousand | -3.48 Million | -105.85 Thousand | -3.45 Million |
| Debt repayment | - | - | - | -3.33 Million | -3.33 Million | -3.4 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 24.97 Thousand | - | 25.55 Thousand |
| Other Financing Activities | -348.79 Thousand | -149 Thousand | - | -181.64 Thousand | 3.22 Million | -77.54 Thousand |
| Accounts receivables | - | - | - | 1.4 Million | - | - |
| Accounts payables | - | - | - | -1.2 Million | - | - |
| Inventory | - | - | - | -883.4 Thousand | - | - |
| Other working capital | - | - | - | -909.69 Thousand | - | - |
| Cash at beginning of period | 7.15 Million | 3.76 Million | 4.76 Million | 11.1 Million | 6.18 Million | 11.1 Million |
| Cash at end of period | 2.35 Million | 1.56 Million | 3.76 Million | 4.76 Million | 4.76 Million | 6.18 Million |
| Capital Expenditure | -574.03 Thousand | -112.69 Thousand | -275.69 Thousand | -542.14 Thousand | -215.95 Thousand | -333.72 Thousand |
| Effect of forex changes on cash | - | - | 105.82 Thousand | -386.63 Thousand | -139.67 Thousand | -138.91 Thousand |
| Net cash flow / Change in cash | -4.8 Million | -2.19 Million | -1 Million | -6.33 Million | -1.41 Million | -4.92 Million |
| Free Cash Flow | -574.03 Thousand | -2.18 Million | -1.02 Million | -4.17 Million | -2.95 Million | -1.24 Million |
BPLPHARMA
3091
0LIU
600983
8967
002396